SCHEMBL7359306

SCHEMBL7359306

CC(C)CN[C@@H](CC(N)=O)C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 4/20 0.44
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
MMP8 P22894 2/20 0.32
MMP1 P03956 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
EPHX1 P07099 1/20 0.31
PDCD1LG2 Q9BQ51 1/20 0.31
CD274 Q9NZQ7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7359311 1.00 ECE1 (0.44) ECE1CYP2D6CYP2C19MMP8MMP1
SCHEMBL14456269 0.90 ECE1 (0.39) ECE1CYP2D6CYP2C19MMP8MMP1
SCHEMBL14199861 0.86 ECE1 (0.47) ECE1CYP2D6CYP2C19MAPTALDH1A1
SCHEMBL17826032 0.81 MAPT (0.44) CYP2D6CYP2C19MMP8MAPTALDH1A1
SCHEMBL19901822 0.81 CYP2D6 (0.38) ECE1CYP2D6CYP2C19MMP8MMP1
SCHEMBL3856802 0.78 ECE1 (0.42) ECE1PDCD1LG2CD274
SCHEMBL7034111 0.78 ECE1 (0.42) ECE1PDCD1LG2CD274
SCHEMBL9905434 0.76 ECE1 (0.41) ECE1PDCD1LG2CD274
SCHEMBL8420550 0.76 ECE1 (0.35) ECE1PDCD1LG2CD274
SCHEMBL8420547 0.76 ECE1 (0.35) ECE1PDCD1LG2CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005448-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS Du Pont Pharmaceuticals Company (US) 2000-06-07 EP disclosed
WO-1999009000-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS DU PONT PHARMACEUTICALS COMPANY (US) 1999-02-25 WO disclosed